Clinical Trial Update: Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A trial update for a platinum and polyadenosine 5'-diphosphoribose polymerisation inhibitor in neoadjuvant treatment for triple-negative breast cancer and/or ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: RECRUITING